SOLUGEN INC

Lobbying for SOLUGEN INC · Industrial Biomanufacturing

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$170,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 4

Defense, Dept of (DOD)
Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 3

HR 4016
Department of Defense Appropriations Act, 2026
S 2572
Department of Defense Appropriations Act, 2026
S 2296
National Defense Authorization Act for Fiscal Year 2026

Lobbying activity 2

Defense

Support the use of bio-based chemicals in the Department of Defense, generally. Department of Defense Appropriations Act, 2026 (H.R.4016/ S.2572 - 119th Congress). National Defense Authorization Act for Fiscal Year 2026 (S.2296 - 119th Congress).

Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.